Can post-market evidence generation be streamlined? FDA-commissioned report proposes solutions
As the FDA seeks to bring a greater focus to improving post-market evidence generation, a new report from the Reagan-Udall Foundation offers some potential solutions to the system it says is too costly and complicated.
The Reagan-Udall Foundation offered more than two dozen recommendations for improving post-market evidence generation systems, including simplifying protocol objectives and increasing patient involvement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.